Charlie Galvin is General Manager for the UK, Ireland, and Canada at Amicus Therapeutics.
Prior to this, Charlie gained a breadth of pharmaceutical experience in market access, policy, commercial management, and marketing roles at Amgen and then Pfizer. Charlie is passionate about making the UK a world leader in science and innovation and that this translates into making a meaningful difference for patients.
Championing this agenda is her mission in her cross-industry roles as chair of the Rare Disease Industry Group, member of the ABPI Board and an industry representative on the NICE methods review working group.
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now